This page is the continuation of reference in support of Section 6a
Cserni, G., Bianchi, S., Boecker, W. et al.(2004). Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 103(2), 358-367. (Retrieved November 21st 2014): https://www.ncbi.nlm.nih.gov/pubmed/15593354
Ellis, M.J., Suman, V.J., Hoog, J. et al. (2011). Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype – ACOSOG Z1031. J Clin Oncol 29, 2342–2349. (Retrieved November 21st 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107749/
Damera, A., Evans, A.J., Cornford, E. J. et al. (2003). Diagnosis of axillary nodal metastases by ultrasound‐guided core biopsy in primary operable breast cancer. Br J Cancer 89, 1310–1313. (Retrieved November 19th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394321/
Fajardo, L. L., Pisano, E. D., Caudry, D.J. et al. (2004). Stereotactic and sonographic large‐core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study. Acad Radiol 11, 293–308. (Retrieved November 19th 2014): https://www.ncbi.nlm.nih.gov/pubmed/15035520
Newman, E. L., Kahn, A., Diehl, K. M. et al. (2006). Does the method of biopsy affect the incidence of sentinel lymph node metastases? Breast J 12, 53–57. (Retrieved November 19th 2014): https://www.ncbi.nlm.nih.gov/pubmed/16409587
Parker, S. H., Burbank, F., Jackman, R. J. et al. (1994). Percutaneous large‐core breast biopsy: a multi‐institutional study. Radiology 193, 359–364. (Retrieved November 21st 2014): https://www.ncbi.nlm.nih.gov/pubmed/7972743
